There is accumulating evidence for the efficacy of lamotrigine in the treatment of bipolar disorder, including bipolar depression, both as monotherapy and in combination with sodium valproate. We present the cases of 3 female patients admitted to our hospital with the diagnosis of schizoaffective disorder who were treated with lamotrigine. While dosages up to 200 mg/day, resulting in serum concentrations of less than 5 mg/l, were only partially effective, 400 mg/day (with serum concentrations ?10 mg/l) led to considerable mood stability, with complete remission from paranoid symptoms. We suggest that lamotrigine might be helpful in the treatment of schizoaffective disorder, probably with serum concentrations of more than 5 mg/l. This 33-year-old bank clerk was admitted 9/97 with a severe valproate [2], a drug known to markedly increase blood schizomanic episode. She was previously diagnosed as schizoaffective levels of lamotrigine [3] . In particular, lamotrigine might disorder, having 6 schizomanic episodes since age 21, with full remission in between. Originally, the disorder started with a severe depresbe helpful in treatment-refractory bipolar disorder [4-6], sion and a suicide attempt in 1986. The patient continuously took rapid-cycling bipolar disorder [7, 8] , bipolar depression lithium since 1993, the last schizomanic episodes were 3/97 and 9/97.
Recently, considerable evidence has accumulated that
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and in combination with
This 33-year-old bank clerk was admitted 9/97 with a severe valproate [2] , a drug known to markedly increase blood schizomanic episode. She was previously diagnosed as schizoaffective levels of lamotrigine [3] . In particular, lamotrigine might disorder, having 6 schizomanic episodes since age 21, with full remission in between. Originally, the disorder started with a severe depresbe helpful in treatment-refractory bipolar disorder [4] [5] [6] , sion and a suicide attempt in 1986. The patient continuously took rapid-cycling bipolar disorder [7, 8] , bipolar depression lithium since 1993, the last schizomanic episodes were 3/97 and 9/97. [9] [10] [11] and bipolar mania [12] .
Lithium was discontinued because of the lack of efficacy, hypothyroidHere we report on 3 female patients admitted to the ism and weight gain. The acute schizomanic episode was treated Munich University Psychiatric Hospital with the diagno-successfully with a sodium valproate loading therapy. After discharge sis of schizoaffective disorder who were consecutively 12/97, the patient developed a severe loss of hair and lamotrigine treated with lamotrigine as monotherapy. All patients was introduced with the aim of substituting for sodium valproate.
Lamotrigine was well tolerated and in 2/98 a serum concentration of had experienced numerous episodes in the past and were 4.8 mg/l was reached with 125 mg of Lamictal Ô . At this point, the not responsive to lithium and/or did not tolerate sodium patient developed a light manic episode without paranoid symptoms valproate. Depressive episodes in the past had frequently which led to admission to our hospital; it was important for the required use of antidepressants with the consecutive risk patient that this was the first time she was not admitted against to induce a new schizomanic episode.
her will. Manic symptoms were considerably diminished by further increasing lamotrigine serum concentrations (9.3 mg/l, administration of 400 mg Lamictal). Mrs. L. is a 31-year-old opera singer who was admitted to our hospital in 11/97 with the diagnosis of schizomanic episode. In the
The history of these patients shows that lamotrigine past 10 years at least 3 depressive and 2 manic episodes were observed can be used safely and successfully in treatment-resistant with full remission in between, at this time she also exhibited severe schizoaffective disorder. Because of the risk of skin rashes thought disorder, delusions and hallucinations leading to a ICDlamotrigine -unlike sodium valproate -cannot be given 10 diagnosis of schizomanic episode. The patient, who is a lithium nonresponder, received lamotrigine. Termination of the schizomanic as a loading therapy. Our cases suggest that, unless serum episode was achieved with dosing up to 300 mg/day Lamictal, leading concentrations of more than 5 mg/l are reached, lamotrito a serum concentration of 7.7 mg/l. After discharge a very light gine does not seem to display its full protective action. depression was observed, no antidepressant medication was necessary. It might be useful to initially combine lamotrigine with other potentially efficacious substances. Once dosed up Case 3 to approximately 400 mg/day, lamotrigine in our patients
The 37-year-old cosmetician was admitted in 6/97 with a severe seemed to be effective in a variety of schizoaffective sympschizomanic episode. Since 1979 the patient was admitted at least 40 toms as paranoid symptoms, hallucinations, thought distimes in different psychiatric hospitals because of mania, severe depression or schizomania. In the last 3 years no full remission was achieved order, manic and depressive symptoms. The efficacy of as a rapid cycling between (schizo)mania and depression had to be ob-lamotrigine in treating the schizophrenic component served despite several therapeutic attempts to influence the disease. Li-parallels the reduction of ketamine effects in healthy huthium was not able to prevent severe manic episodes, carbamazepine mans reported by Anand et al. [13] and might be mediated was equally ineffective and sodium valproate led to hair loss. The epi-by reduction of glutamate release. The efficacy of lamotrisode in 6/97 was treatment-resistant to high doses of flupentixol as well gine in reducing depressive symptoms might be linked to as to 25 mg of olanzapine. A therapy with lamotrigine was started and 5-HT uptake inhibition, an effect described in both rat discharge was possible in 8/97. Unfortunately, in 12/97 depression and severe suicidal thoughts developed despite 200 mg of Lamictal mono-and human tissue by Southam et al. [14] .
therapy (serum concentration of 2.4 mg/l), consecutively lamotrigine In summary, further studies and long-term observawas combined with 150 mg of venlafaxine. This strategy led to induc-tion of the effects of high doses of lamotrigine are necestion of a new schizomanic episode. At this point, venlafaxine was dis-sary; because of its dual action on both glutamate and 5-continued and cis-clopentixol added to lamotrigine. In 1/98 discharge HT neurotransmission, lamotrigine might be particularly was possible, the last serum concentration of lamotrigine was 5.1 mg/ useful in the treatment of schizoaffective disorder. ml (400 mg Lamictal). Cis-clopentixol was discontinued. In 3/98 a light depression without suicidal thoughts was observed, no antidepressant drug was prescribed at this point.
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